Literature DB >> 18194181

Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study.

Alberto Galvão Teles1, Mário Carreira, Violeta Alarcão, D Sociol, José Maria Aragüés, Luís Lopes, Mário Mascarenhas, Joaquim Garcia E Costa.   

Abstract

INTRODUCTION: Many studies of the prevalence of erectile dysfunction have been conducted in several countries. This is the first Portuguese study that provides current and comparative data on the prevalence of erectile dysfunction. AIM: The main objective was to estimate the prevalence of erectile dysfunction in men aged 40 to 69 years and correlate erectile dysfunction to certain risk factors. MAIN OUTCOME MEASURES: Evaluation of erectile dysfunction was achieved using the International Index of Erectile Function (IIEF), a 15-item questionnaire that has been developed and validated as a brief and reliable self-administered scale for accessing erectile function.
METHODS: The Portuguese Erectile Dysfunction Study was based on a questionnaire that included socio-demographic variables, information on lifestyle and risk factors, and the IIEF. In total, 3,548 questionnaires were administered to men aged 40 to 69 years in 50 primary healthcare centers between July 2004 and January 2005 in a combination of both self-administration and interviews. Erectile dysfunction was defined as the inability to achieve and maintain an erection sufficient to permit satisfactory sexual intercourse.
RESULTS: The response rate was 81.3%. The total prevalence of erectile dysfunction was 48.1% (age-adjusted). Prevalence increases with age: 29%, 50%, and 74% in men aged 40 to 49 years, 50 to 59 years, and 60 to 69 years, respectively. Severity of erectile dysfunction also increases with age: 1%, 2%, and 10% of complete erectile dysfunction in men aged 40 to 49 years, 50 to 59 years, and 60 to 69 years, respectively.
CONCLUSIONS: The prevalence of erectile dysfunction is strongly related to age. There is also a correlation with the health status of participants.

Entities:  

Mesh:

Year:  2008        PMID: 18194181     DOI: 10.1111/j.1743-6109.2007.00745.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  16 in total

1.  Mobilisation of endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing erectile dysfunction in diabetic rats.

Authors:  Xue-Feng Qiu; Xiao-Xin Li; Yun Chen; Hao-Cheng Lin; Wen Yu; Run Wang; Yu-Tian Dai
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

Review 2.  What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng.

Authors:  Mark A Moyad; Kwangsung Park
Journal:  Asian J Androl       Date:  2012-09-24       Impact factor: 3.285

3.  Modern utilization of penile prosthesis surgery: a national claim registry analysis.

Authors:  R L Segal; S B Camper; A L Burnett
Journal:  Int J Impot Res       Date:  2014-05-15       Impact factor: 2.896

4.  Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.

Authors:  Robert Segal; Johanna L Hannan; Xiaopu Liu; Omer Kutlu; Arthur L Burnett; Hunter C Champion; Jae Hyung Kim; Jochen Steppan; Dan E Berkowitz; Trinity J Bivalacqua
Journal:  J Androl       Date:  2012-04-05

5.  Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial.

Authors:  Rena R Wing; Raymond C Rosen; Joseph L Fava; Judy Bahnson; Frederick Brancati; Isaias Noel C Gendrano Iii; Abbas Kitabchi; Stephen H Schneider; Thomas A Wadden
Journal:  J Sex Med       Date:  2009-08-17       Impact factor: 3.802

6.  The relation between erectile dysfunction and extent of coronary artery disease in the patients with stable coronary artery disease.

Authors:  Hikmet Hamur; Hakan Duman; Ercument Keskin; Sinan Inci; Zafer Kucuksu; Husnu Degirmenci; Ergun Topal
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Sexual dysfunction in males with systolic heart failure and associated factors.

Authors:  Sharareh Zeighami Mohammadi; Mandana Shahparian; Farzad Fahidy; Ebrahim Fallah
Journal:  ARYA Atheroscler       Date:  2012

8.  Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis.

Authors:  Hanna Pohjantähti-Maaroos; Ari Palomäki; Juha Hartikainen
Journal:  BMC Cardiovasc Disord       Date:  2011-06-27       Impact factor: 2.298

9.  Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa.

Authors:  Fabio Guagnini; Mara Ferazzini; Marco Grasso; Salvatore Blanco; Tiziano Croci
Journal:  J Transl Med       Date:  2012-03-23       Impact factor: 5.531

Review 10.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.